Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Predictive and Diagnostic Value of Using Cystatin C and High Sensitive Troponin Level Together for Diagnosis of ACS in Patients With Chronic Kidney Disease Coming to Emergency Department With Chest Pain

NCT05303441 is registered in ClinicalTrials.gov with Ankara Diskapi Training and Research Hospital as lead sponsor.

NCT NCT05303441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05303441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Predictive and Diagnostic Value of Using Cystatin C and High Sensitive Troponin Level Together for Diagnosis of ACS in Patients With Chronic Kidney Disease Coming to Emergency Department With Chest Pain
Lead sponsor
Ankara Diskapi Training and Research Hospital
Phase
Observational
Overall status
Unknown status
Start date
March 7, 2022
Completion date
February 1, 2023
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, chronic kidney diseases